Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific...
Intelligent Bio Solutions GAAP EPS of -$8.44, revenue of $4.22M
12 Health Care Stocks Moving In Wednesday's Intraday Session
Intelligent Bio Solutions | 8-K: FY2026 Revenue: USD 4.215 M
INBS: Revenue up 38% to $4.2M, gross margin 48.63%, FDA submission on track for late 2026
Intelligent Bio Solutions FY26 net loss widens to $12.47 million; revenue rises 38% to $4.2 million
Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?